WallStreetZenWallStreetZen

NASDAQ: SGRY
SURGERY PARTNERS INC Stock Forecast, Predictions & Price Target

Analyst price target for SGRY

Based on 7 analysts offering 12 month price targets for SURGERY PARTNERS INC.
Min Forecast
$50.00+24.25%
Avg Forecast
$60.43+50.17%
Max Forecast
$73.00+81.41%

Should I buy or sell SGRY stock?

Based on 7 analysts offering ratings for SURGERY PARTNERS INC.
Buy
Strong Buy
3 analysts 42.86%
Buy
2 analysts 28.57%
Hold
2 analysts 28.57%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

SGRY stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
Citigroup
Bottom 24%
24
Strong BuyMaintains$64.00+59.05%2022-05-04
JP Morgan
Top 26%
75
HoldMaintains$55.00+36.68%2022-03-02
SVB Leerink
Top 38%
63
BuyMaintains$65.00+61.53%2022-03-02
RBC Capital
Bottom 22%
22
BuyMaintains$65.00+61.53%2022-03-01
Barclays
Bottom 9%
9
Strong BuyInitiates Coverage On$73.00+81.41%2021-11-30
Stifel Nicolaus
Bottom 39%
39
Strong BuyUpgrades$51.00+26.74%2021-11-29
Anonymous
JP Morgan
HoldInitiates Coverage On$50.00+24.25%2021-11-01
Cowen & Co.
Bottom 7%
7
HoldInitiates Coverage On$50.00+24.25%2021-09-10

1 of 1

Forecast return on equity

Is SGRY forecast to generate an efficient return?
Company
6.43%
Industry
-126.04%
Market
31.09%
SGRY's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is SGRY forecast to generate an efficient return on assets?
Company
1.19%
Industry
8.38%
SGRY is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

SGRY earnings per share forecast

What is SGRY's earnings per share in the next 3 years based on estimates from 3 analysts?
Avg 1 year Forecast
$0.10
Avg 2 year Forecast
$0.44
Avg 3 year Forecast
$0.51

SGRY revenue forecast

What is SGRY's revenue in the next 3 years based on estimates from 5 analysts?
Avg 1 year Forecast
$2.6B+11.02%
Avg 2 year Forecast
$2.9B+24.25%
Avg 3 year Forecast
$3.2B+40.17%
SGRY's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

SGRY revenue growth forecast

How is SGRY forecast to perform vs Medical Care Facilities companies and vs the US market?
Company
11.67%
Industry
8.55%
Market
9.17%
SGRY's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
SGRY's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

SGRY vs Medical Care Facility Stocks

TickerPricePrice TargetUp/downsideConsensus
SGRY$40.24$60.43+50.17%Buy
AMED$117.53$186.23+58.45%Buy
SEM$24.70$35.00+41.70%Buy
AMN$95.63$138.50+44.83%Strong Buy
LFST$7.75$14.60+88.39%Hold

SURGERY PARTNERS Stock Forecast FAQ

Is SURGERY PARTNERS Stock a good buy in 2022, according to Wall Street analysts?

The consensus among 7 Wall Street analysts covering (NASDAQ: SGRY) stock is to Buy SGRY stock.

Out of 7 analysts, 3 (42.86%) are recommending SGRY as a Strong Buy, 2 (28.57%) are recommending SGRY as a Buy, 2 (28.57%) are recommending SGRY as a Hold, 0 (0%) are recommending SGRY as a Sell, and 0 (0%) are recommending SGRY as a Strong Sell.

What is SGRY's earnings growth forecast for 2022-2024?

(NASDAQ: SGRY) SURGERY PARTNERS's forecast annual earnings growth rate of N/A is not forecast to beat the US Medical Care Facilities industry's average forecast earnings growth rate of 4.85%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 15.67%.

SURGERY PARTNERS's earnings in 2022 is -$37,700,000.On average, 3 Wall Street analysts forecast SGRY's earnings for 2022 to be $8,990,430, with the lowest SGRY earnings forecast at -$12,586,602, and the highest SGRY earnings forecast at $26,072,247. On average, 3 Wall Street analysts forecast SGRY's earnings for 2023 to be $39,557,892, with the lowest SGRY earnings forecast at $16,182,774, and the highest SGRY earnings forecast at $53,942,579.

In 2024, SGRY is forecast to generate $45,851,192 in earnings, with the lowest earnings forecast at $45,851,192 and the highest earnings forecast at $45,851,192.

What is SGRY's revenue growth forecast for 2022-2024?

(NASDAQ: SGRY) SURGERY PARTNERS's forecast annual revenue growth rate of 11.67% is forecast to beat the US Medical Care Facilities industry's average forecast revenue growth rate of 8.55%, and and it is also forecast to beat the US market's average forecast revenue growth rate of 9.17%.

SURGERY PARTNERS's revenue in 2022 is $2,308,900,000.On average, 5 Wall Street analysts forecast SGRY's revenue for 2022 to be $230,463,556,994, with the lowest SGRY revenue forecast at $228,338,938,600, and the highest SGRY revenue forecast at $233,194,669,789. On average, 5 Wall Street analysts forecast SGRY's revenue for 2023 to be $257,918,172,206, with the lowest SGRY revenue forecast at $251,337,357,327, and the highest SGRY revenue forecast at $265,869,488,218.

In 2024, SGRY is forecast to generate $290,957,282,854 in revenue, with the lowest revenue forecast at $285,140,474,708 and the highest revenue forecast at $296,774,090,999.

What is SGRY's forecast return on assets (ROA) for 2022-2025?

(NASDAQ: SGRY) forecast ROA is 1.19%, which is lower than the forecast US Medical Care Facilities industry average of 8.38%.

What is SGRY's Price Target?

According to 7 Wall Street analysts that have issued a 1 year SGRY price target, the average SGRY price target is $60.43, with the highest SGRY stock price forecast at $73.00 and the lowest SGRY stock price forecast at $50.00.

On average, Wall Street analysts predict that SURGERY PARTNERS's share price could reach $60.43 by May 4, 2023. The average SURGERY PARTNERS stock price prediction forecasts a potential upside of 50.17% from the current SGRY share price of $40.24.

What is SGRY's Earnings Per Share (EPS) forecast for 2022-2024?

(NASDAQ: SGRY) SURGERY PARTNERS's current Earnings Per Share (EPS) is -$0.46. On average, analysts forecast that SGRY's EPS will be $0.10 for 2022, with the lowest EPS forecast at -$0.14, and the highest EPS forecast at $0.29. On average, analysts forecast that SGRY's EPS will be $0.44 for 2023, with the lowest EPS forecast at $0.18, and the highest EPS forecast at $0.60. In 2024, SGRY's EPS is forecast to hit $0.51 (min: $0.51, max: $0.51).

What is SGRY's forecast return on equity (ROE) for 2022-2025?

(NASDAQ: SGRY) forecast ROE is 6.43%, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.